Business Insights | PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Fri, 24 May 2024 13:42:52 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png Business Insights | PharmaTimes https://pharmatimes.com 32 32 232894315 One direction https://pharmatimes.com/business_insights/one-direction/ Fri, 24 May 2024 13:32:42 +0000 https://pharmatimes.com/?post_type=business_insights&p=101757 Data strategies differ depending on a customer’s scale and their therapeutic focus. There is no universal solution, however we see all customers striving to create a more data-driven future. The combination of the need for data insights and the complexity around supporting different therapeutic areas is common. Against this backdrop, customers are striving to enrich […]

]]>
101757
New age https://pharmatimes.com/business_insights/new-age/ Fri, 24 May 2024 12:30:19 +0000 https://pharmatimes.com/?post_type=business_insights&p=101737 Freddie Lewis is Medical Director at Havas Lynx Group

]]>
101737
Big rethink https://pharmatimes.com/business_insights/big-rethink/ Fri, 26 Apr 2024 14:18:42 +0000 https://pharmatimes.com/?post_type=business_insights&p=101537 Diversity of thought creates meaningful work

]]>
101537
All things being equal https://pharmatimes.com/business_insights/all-things-being-equal/ Fri, 26 Apr 2024 14:09:37 +0000 https://pharmatimes.com/?post_type=business_insights&p=101535 Going beyond diversity to create equity across pharma

]]>
101535
Blueprint for inclusion https://pharmatimes.com/business_insights/blueprint-for-inclusion/ Thu, 14 Mar 2024 15:46:48 +0000 https://pharmatimes.com/?post_type=business_insights&p=101235 How our industry can support women at work – a case study from Kyowa Kirin International

]]>
101235
Back to the future https://pharmatimes.com/business_insights/back_to_the_future_1450288/ Tue, 21 Jun 2022 15:42:00 +0000 https://pharmatimes.com/business-insights/back_to_the_future_1450288/ Why is CVD a key focus area for Daiichi Sankyo Europe?Aspiring to protect every life from cardiovascular disease (CVD) is a key focus at Daiichi Sankyo Europe – and a professional mission for me. The global pandemic highlights this in a way never seen before. Even prior to COVID-19, CVD was a high-profile challenge for […]

]]>
7247
Smart people insights – Jon Beauchamp https://pharmatimes.com/business_insights/smart_people_insight_jon_beauchamp/ Tue, 02 Nov 2021 11:00:00 +0000 https://pharmatimes.com/business-insights/smart_people_insight_jon_beauchamp/ Tell us about argenx argenx is a global immunology company developing innovative potential therapies to help improve the lives of people suffering from severe autoimmune diseases and cancer. The company was founded in Europe in 2008 on a ground-breaking antibody engineering discovery – using the diversity of the llama immune system to build differentiated human […]

]]>
7245
Monaco https://pharmatimes.com/business_insights/monaco_a_destination_where_medical_ethics_are_always_respected/ Tue, 02 Nov 2021 10:59:00 +0000 https://pharmatimes.com/business-insights/monaco_a_destination_where_medical_ethics_are_always_respected/ Keeping up with the trends and new innovation – while remaining reactive – is how Monaco, as a nation and a business destination, aims to thrive. The world’s most famous principality has a proud history of pioneering medical exc ellence and always ensures that there is a connection between the theme of a congress and […]

]]>
7243
Smart people insights – Fleur Chandler https://pharmatimes.com/business_insights/smart_people_insight_fleur_chandler/ Wed, 28 Apr 2021 14:29:00 +0000 https://pharmatimes.com/business-insights/smart_people_insight_fleur_chandler/ This article was sponsored by Sanofi What are combination therapies and how can they improve outcomes for cancer patients? Combination therapies are becoming increasingly commonplace and are seen to be the future of oncology treatment. These are two or more treatments used together to target multiple pathways involved in the complex pathophysiology of cancer.1, 2 […]

]]>
7241
Solving this century’s grand challenges https://pharmatimes.com/business_insights/solving_this_centurys_grand_challenges/ Tue, 06 Apr 2021 15:18:00 +0000 https://pharmatimes.com/business-insights/solving_this_centurys_grand_challenges/ The modern pharmaceutical industry is being driven by biologics. Whether it’s monoclonal antibodies, gene therapy or new mRNA vaccines targeting Covid-19, engineering these molecules requires a unique set of skills. “There’s been big changes in the sector over the past two decades. Chemical and biological engineering is more important now in pharma where we see […]

]]>
7239